Business Description
Indoco Remedies Ltd
ISIN : INE873D01024
Total Employee Number:
6,053Compare
Compare
Traded in other countries / regions
532612.India IPO Date
2005-01-14Description
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.16 | |||||
Debt-to-EBITDA | 7.66 | |||||
Interest Coverage | 0.13 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.64 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.2 | |||||
3-Year EBITDA Growth Rate | -19.9 | |||||
3-Year Book Growth Rate | -3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.31 | |||||
9-Day RSI | 57.23 | |||||
14-Day RSI | 58.7 | |||||
3-1 Month Momentum % | 9.86 | |||||
6-1 Month Momentum % | 13.56 | |||||
12-1 Month Momentum % | -27.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.75 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 280.55 | |||||
Days Sales Outstanding | 87.91 | |||||
Days Payable | 179.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.08 | |||||
3-Year Dividend Growth Rate | -48.9 | |||||
Forward Dividend Yield % | 0.08 | |||||
5-Year Yield-on-Cost % | 0.06 | |||||
Shareholder Yield % | -5.4 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.76 | |||||
Operating Margin % | 0.86 | |||||
Net Margin % | -5.31 | |||||
EBITDA Margin % | 7.94 | |||||
FCF Margin % | 5.64 | |||||
OCF Margin % | 12.64 | |||||
ROE % | -9.71 | |||||
ROA % | -3.79 | |||||
ROIC % | 0.65 | |||||
3-Year ROIIC % | -17.42 | |||||
ROC (Joel Greenblatt) % | 0.9 | |||||
ROCE % | 1.01 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 44.38 | |||||
Shiller PE Ratio | 43.46 | |||||
PS Ratio | 1.19 | |||||
PB Ratio | 2.45 | |||||
Price-to-Tangible-Book | 3.11 | |||||
Price-to-Free-Cash-Flow | 21.96 | |||||
Price-to-Operating-Cash-Flow | 9.8 | |||||
EV-to-EBIT | 211.74 | |||||
EV-to-EBITDA | 23.44 | |||||
EV-to-Forward-EBITDA | 9.16 | |||||
EV-to-Revenue | 1.87 | |||||
EV-to-Forward-Revenue | 1.88 | |||||
EV-to-FCF | 34.01 | |||||
Price-to-GF-Value | 0.69 | |||||
Price-to-Projected-FCF | 5.75 | |||||
Earnings Yield (Greenblatt) % | 0.47 | |||||
FCF Yield % | 4.4 | |||||
Forward Rate of Return (Yacktman) % | -16.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indoco Remedies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 17,911.5 | ||
| EPS (TTM) (₹) | -10.71 | ||
| Beta | 2.0447 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.3 | ||
| Volatility % | 45.63 | ||
| 14-Day RSI | 58.7 | ||
| 14-Day ATR (₹) | 11.351937 | ||
| 20-Day SMA (₹) | 241.762 | ||
| 12-1 Month Momentum % | -27.66 | ||
| 52-Week Range (₹) | 162.19 - 349.8 | ||
| Shares Outstanding (Mil) | 92.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indoco Remedies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indoco Remedies Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-06 15:30 | In 114 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 113 days | ||
| General meeting for 2026 | 2026-09-11 10:30 | In 58 days | ||
| Annual report for 2026 | 2026-08-14 | In 29 days | ||
| First quarter earnings conference call for 2027 | 2026-07-24 15:30 | In 9 days | ||
| First quarter earnings results for 2027 | 2026-07-24 | In 8 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-07 15:30 | 228.68 (+4.71%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-07 | 228.68 (+4.71%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-03 15:30 | 211.94 (+0.92%) | ||
| Third quarter earnings results for 2026 | 2026-02-03 | 211.94 (+0.92%) |
Show
Entries
Indoco Remedies Ltd Frequently Asked Questions
What is Indoco Remedies Ltd(NSE:INDOCO)'s stock price today?
The current price of NSE:INDOCO is ₹249.57. The 52 week high of NSE:INDOCO is ₹349.80 and 52 week low is ₹162.19.
When is next earnings date of Indoco Remedies Ltd(NSE:INDOCO)?
The next earnings date of Indoco Remedies Ltd(NSE:INDOCO) is 2026-07-24 Est..
Does Indoco Remedies Ltd(NSE:INDOCO) pay dividends? If so, how much?
The Dividend Yield %  of Indoco Remedies Ltd(NSE:INDOCO) is 0.08% (As of Today), Highest Dividend Payout Ratio of Indoco Remedies Ltd(NSE:INDOCO) was 0.32. The lowest was 0.02. And the median was 0.09. The  Forward Dividend Yield % of Indoco Remedies Ltd(NSE:INDOCO) is 0.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Indoco Remedies Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers